Updated:
Hangzhou Diagens Biotechnology Co., Ltd.
No public founding date or named founder is available for Hangzhou Diagens Biotechnology Co., Ltd. The firm operates as a manufacturer of in-vitro diagnostic...
Hangzhou Diagens Biotechnology Co., Ltd.
No public founding date or named founder is available for Hangzhou Diagens Biotechnology Co., Ltd. The firm operates as a manufacturer of in-vitro diagnostic products, including reagents and instruments for clinical chemistry, immunoassay, and molecular diagnostics, serving hospital and laboratory customers primarily in China's domestic market. The company's product portfolio spans routine biochemical assays, infectious disease testing, tumor markers, and thyroid function panels. It also provides fully automated analyzers and supporting software for lab workflow integration. Diagens markets its solutions to tier-2 and tier-3 hospitals in China and has reported exports to Southeast Asia and Africa. No team size, executive roster, or AUM figures are publicly available. No philanthropic or adjacent investment vehicles have been identified. As a manufacturer of diagnostic products, Diagens' structural differentiator lies in its integrated approach: developing both reagents and instruments for a closed-system workflow, which is common among Chinese IVD firms seeking to reduce dependency on foreign suppliers. No succession or governance details are available.
General information
Firm type
other
Location
Region
Asia
Country
China
City
Hangzhou
Corporate office
Hangzhou, Zhejiang, China
Sector focus
Frequently asked questions
Who runs investment decisions at Hangzhou Diagens Biotechnology Co., Ltd.?
No executive leadership or investment decision-makers are identified in public records for this firm. It is an operating company, not a fund or family office, and does not appear to have an investment committee structure.
What investment stages does Hangzhou Diagens Biotechnology Co., Ltd. typically target?
The firm does not function as an investment entity. It is an operating company manufacturing diagnostic products, and no investment stage targeting is publicly documented.
Which sectors does Hangzhou Diagens Biotechnology Co., Ltd. explicitly avoid?
No explicit sector avoidance has been disclosed. The firm's known activity is confined to the diagnostic and laboratory equipment sector within the healthcare industry.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on investors?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: